News
Cardiff Oncology, a clinical-stage biotechnology firm, develops novel therapies for the treatment of various cancers. Read ...
Actuate Therapeutics' elraglusib shows promise in metastatic pancreatic cancer. Upcoming FDA meeting may accelerate approval.
- GAAP revenue reached $158.8 million in Q2 2025, exceeding analyst GAAP revenue estimates by $4.6 million and up 6% year over year. - Active patients on therapy climbed to 4,331, supported by new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback